Related Experiment Video
Updated: Sep 21, 2025
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
[Annual review of venous thromboembolism in 2021]
1Peking University China-Japan Friendship School of Clinical Medicine, Beijing 100029, China.
Abstract:
In the past year, significant progress has been made in the field of venous thromboembolism (VTE) including risk assessment and anticoagulation prevention, diagnostic strategies and model exploration, new drug development and disease management. Particularly, major breakthroughs have been made in the prevention of VTE with FXI inhibitors and the prevention of novel coronavirus pneumonia with coagulation alterations and anticoagulation interventions. Here, we reviewed the progress and achievements in the field of VTE in the past year, aiming to provide evidence and ideas for the diagnosis, treatment and future studies of VTE.
Insights
Recent advancements in venous thromboembolism (VTE) include novel FXI inhibitors for prevention and anticoagulation strategies for COVID-19. This review highlights key progress in VTE diagnosis, treatment, and future research directions.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pharmacology
Background:
- Venous thromboembolism (VTE) remains a significant clinical challenge.
- Recent research has focused on improving VTE risk assessment, diagnosis, and management.
- Understanding coagulation alterations in novel coronavirus pneumonia has also advanced anticoagulation interventions.
Purpose of the Study:
- To review significant progress in venous thromboembolism (VTE) over the past year.
- To highlight breakthroughs in VTE prevention, particularly with FXI inhibitors.
- To discuss advancements in diagnosing and managing VTE and related conditions like COVID-19.
Main Methods:
- Comprehensive literature review of recent studies on VTE.
- Analysis of new drug development, including FXI inhibitors.
- Evaluation of diagnostic strategies and risk assessment models for VTE.
- Examination of anticoagulation interventions in VTE and COVID-19.
Main Results:
- Significant progress in VTE risk assessment and anticoagulation prevention.
- Major breakthroughs in VTE prevention using FXI inhibitors.
- Advancements in understanding coagulation alterations and anticoagulation for novel coronavirus pneumonia.
Conclusions:
- The past year has seen substantial achievements in the field of VTE.
- New therapeutic targets and strategies are emerging for VTE prevention and treatment.
- This review provides valuable insights for clinical practice and future research in VTE.
